SU943578A1 - Heparin daily dose determination method - Google Patents
Heparin daily dose determination method Download PDFInfo
- Publication number
- SU943578A1 SU943578A1 SU802996502A SU2996502A SU943578A1 SU 943578 A1 SU943578 A1 SU 943578A1 SU 802996502 A SU802996502 A SU 802996502A SU 2996502 A SU2996502 A SU 2996502A SU 943578 A1 SU943578 A1 SU 943578A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- heparin
- patient
- units
- blood
- daily dose
- Prior art date
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Description
(54) СПОСОБ ОПРЕДЕЛЕНИЯ СУТОЧНОЙ ДОЗЫ ГЕПАРИНА(54) METHOD FOR DETERMINING DAY HEPARIN DOSE
1one
лl
Изобретение относитс к медицине, в част кости к профилактике и лечению заболевани , св занных с патологическим повышением активности свертывающей системы крови различной этиологии.The invention relates to medicine, in particular bone to the prevention and treatment of disease, associated with the pathological increase in the activity of the blood coagulation system of various etiologies.
Наиболее близким решением к изобретению по своей сущности и достигаемому результату вл етс известный способ определени суточной дозы гепарина, предусматривающий расчет ето дозы на единицу массы тела больного или на еданицу площади его поверхности tUОднако -известный способ не обеспечивает необходимой точности дозировки гепарина.The closest solution to the invention in its essence and the achieved result is the well-known method for determining the daily dose of heparin, which involves calculating this dose per patient’s body mass or per unit surface area tU. However, the well-known method does not provide the necessary accuracy of heparin dosage.
Целью изобретени вл етс повышение точности дозировки препарата.The aim of the invention is to improve the accuracy of the dosage of the drug.
Указанна цель достигаетс тем, что в способе определени суточной дозы гепарина отличительной особенностью вл етс то, что определ ют массу тела больного и концентрацию эндогенного гепарина в крови больного, и суточную дозу гепарина рассчитывают по формулеThis goal is achieved by the fact that in the method of determining the daily dose of heparin, the distinguishing feature is that the patient's body weight and the concentration of endogenous heparin in the patient's blood are determined, and the daily dose of heparin is calculated by the formula
..
где X - искома суточна дол гепарина, ед.; А - концентраци эндогенного гепарина в момент исследовани в крови больного , ед/мл крови; where X is the required daily dose of heparin, ed .; A is the concentration of endogenous heparin at the time of examination in the patient’s blood, units / ml of blood;
В концентраци эндогенного гепарина в норме, ед/мл крови; С - масса тела больного. Способ осуществл ют следующим образом. Известным методом определ ют концентрацию эндогенного гепарина в единицах действи (ЕД) на 1 мл крови больного и массу его тела в кг и на основании полученных данных рассчитывают суточную дозу гепарина по следующей формулеThe concentration of endogenous heparin is normal, u / ml of blood; C - body weight of the patient. The method is carried out as follows. The concentration of endogenous heparin in units of action (AU) per 1 ml of patient’s blood and body weight in kg is determined by a known method and, based on the data obtained, calculate the daily dose of heparin using the following formula
А-ззз мA-zzz m
.)i..) i.
-№-№
хЧ xh
где X - искома суточна доза гепарина, ед.;where X is the required daily dose of heparin, ed .;
А - концентраци эндогенного гепарина в момент исследовани в крови больного , ед/мл крови;A is the concentration of endogenous heparin at the time of examination in the patient’s blood, units / ml of blood;
В - концентраци эндогенного гепарина в норме, ед/мл крови;B - normal endogenous heparin concentration, u / ml of blood;
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU802996502A SU943578A1 (en) | 1980-07-10 | 1980-07-10 | Heparin daily dose determination method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU802996502A SU943578A1 (en) | 1980-07-10 | 1980-07-10 | Heparin daily dose determination method |
Publications (1)
Publication Number | Publication Date |
---|---|
SU943578A1 true SU943578A1 (en) | 1982-07-15 |
Family
ID=20923184
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU802996502A SU943578A1 (en) | 1980-07-10 | 1980-07-10 | Heparin daily dose determination method |
Country Status (1)
Country | Link |
---|---|
SU (1) | SU943578A1 (en) |
-
1980
- 1980-07-10 SU SU802996502A patent/SU943578A1/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hrushesky et al. | The respiratory sinus arrhythmia: a measure of cardiac age | |
OM | Renin activity in blood from patients with hypertension. | |
Quail et al. | Thoracic resistivity for stroke volume calculation in impedance cardiography | |
Maselli et al. | Comparison of sympathetic skin response with quantitative sudomotor axon reflex test in diabetic neuropathy | |
Hansen et al. | The effect of different sulfonamides on phenytoin metabolism in man | |
Slutsky et al. | Effect of nitrates on left ventricular size and function during exercise: comparison of sublingual nitroglycerin and nitroglycerin paste | |
Koup et al. | Ethosuximide pharmacokinetics in a pregnant patient and her newborn | |
Yasmineh et al. | Serial serum creatine phosphokinase MB isoenzyme activity after myocardial infarction. Studies in the baboon and man. | |
SU943578A1 (en) | Heparin daily dose determination method | |
Jensen et al. | Temporal muscle blood flow in common migraine | |
Chevreaud et al. | Thallium 201 muscle scintigraphy: application to the management of patients with arterial occlusive disease | |
Lubran et al. | March haemoglobinuria | |
Rambaud et al. | Assessment of the accuracy of segmental perfusion under an occluding balloon for measuring the intrajejunal secretion of albumin and immunoglobulin A. | |
Light et al. | Convenient monitoring of cardiac output and global left ventricular function by transcutaneous aortovelography—an update | |
SU1239601A1 (en) | Method of determining rehabilitation initiation time in case of myocardial infarction | |
Magee et al. | Syringomyelia: loss of deep-pain sensation with otherwise normal sensory perception | |
Igarash | Cardiac function and myocardial metabolism during tachycardia induced by atrial and ventricular pacing | |
RU1792321C (en) | Method of determining indications for urgent surgery in acute calculous pyelonephritis | |
SU1755200A1 (en) | Method for diagnostics of chronic pancreatitis | |
DE3874543D1 (en) | DIAGNOSIS OF OBESITY, CAUSED BY A GENETIC ABNORMALITY, AND METHOD FOR THERAPEUTIC TREATMENT OF GENETICALLY OBESITY. | |
SU1139413A1 (en) | Method of diagnosis of cardiogenic shock | |
EP1272212B1 (en) | Migraine and vasodilation treatment | |
SU1405842A1 (en) | Method of treatment of hepatic diseases | |
Naheedy et al. | Diagnosis of thrombotic giant basilar artery aneurysm on computed tomographic scan | |
SU1219054A1 (en) | Method of determining the degree of seriousness of syocardial infarction |